Background Currently, melatonin is used to treat children and adolescents with insomnia
without knowing the full extent of the short-term and long-term consequences. Our aim was …

Background Melatonin prescriptions for children and adolescents have increased
substantially during the last decade. Existing clinical recommendations focus on melatonin …

Background Melatonin has become a widely used slee** aid for young individuals
currently not included in existing guidelines. The aim was to develop a recommendation on …

The Nordic countries have rather homogenous populations and similar health care systems,
and one could therefore expect comparable levels of psychopathology and psychotropic …

Use of benzodiazepines (BZ) and related drugs is subject to considerable debate due to
problems with dependency and adverse events. We aimed to describe and compare their …

We aimed to provide a detailed description of the use of melatonin in Danish children,
adolescents, and young adults during 2012–2019. We identified melatonin users 0–24 …

The ongoing opioid epidemic has been a global concern for years, increasingly due to its
heavy toll on young people's lives and prospects. Few studies have investigated trends in …

The sleep–wake cycle is a complex multifactorial process involving several
neurotransmitters, including acetylcholine, norepinephrine, serotonin, histamine, dopamine …

Introduction Exogenous melatonin is regulated as a drug in the UK and EU but is available
as an over-the-counter dietary supplement in the US and Canada. In the last 15 years …

The objective of the study was to compare the use of attention deficit hyperactivity disorder
(ADHD) medication among children and adolescents in Scandinavia 2010–2020. Using …